# Filing Detail

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001104659-22-050961
Filing Date
2022-04-27
Accepted
2022-04-27 14:12:26
Documents
17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | F-1/A | tm2132809-21_f1a.htm | F-1/A | 3176200
2 | EXHIBIT 23.1 | tm2132809d25_ex23-1.htm | EX-23.1 | 2897
3 | GRAPHIC | lg_belitebio-4clr.jpg | GRAPHIC | 8853
4 | GRAPHIC | lg_friedmanllp-4c.jpg | GRAPHIC | 33725
5 | GRAPHIC | tm2132809d1-fc_beltebw.jpg | GRAPHIC | 62825
6 | GRAPHIC | tm2132809d1-ph_proofbwlr.jpg | GRAPHIC | 151369
7 | GRAPHIC | tm2132809d10-ph_lesion4c.jpg | GRAPHIC | 3724509
8 | GRAPHIC | tm2132809d4-bc_serum4clr.jpg | GRAPHIC | 67385
9 | GRAPHIC | tm2132809d4-lc_dosing4clr.jpg | GRAPHIC | 71291
10 | GRAPHIC | tm2132809d4-lc_optic4clr.jpg | GRAPHIC | 158215
11 | GRAPHIC | tm2132809d4-lc_reduct4clr.jpg | GRAPHIC | 81600
12 | GRAPHIC | tm2132809d4-ph_babys4clr.jpg | GRAPHIC | 110230
13 | GRAPHIC | tm2132809d4-ph_disease4clr.jpg | GRAPHIC | 159644
14 | GRAPHIC | tm2132809d4-ph_lbs4clr.jpg | GRAPHIC | 235878
15 | GRAPHIC | tm2132809d4-ph_segment4clr.jpg | GRAPHIC | 163034
16 | GRAPHIC | tm2132809d25_ex23-1.jpg | GRAPHIC | 6638
17 | GRAPHIC | tm2132809d25_ex23-1img001.jpg | GRAPHIC | 37731
| Complete submission text file | 0001104659-22-050961.txt |  | 10165107

Mailing Address 5820 OBERLIN DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address 5820 OBERLIN DRIVE, SUITE 101 SAN DIEGO CA 92121 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-264134 | Film No.: 22858735
SIC: 2834 Pharmaceutical Preparations